Dawson James Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Dawson James
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Dawson James. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Dawson James.

Company	Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price
BYRN Byrna Technologies	9/27/2023	Downgraded by	Dawson James		Buy -> Neutral		Low
XXII 22nd Century Group	8/15/2023	Target Lowered by	Dawson James		Buy -> Buy	$10.00 -> $7.50	Low
XXII 22nd Century Group	7/25/2023	Target Lowered by	Dawson James			$15.00 -> $10.00	Low
BYRN Byrna Technologies	7/12/2023	Target Lowered by	Dawson James			$9.50 -> $7.25	Low
TOON Kartoon Studios	7/11/2023	Target Lowered by	Dawson James			$12.50 -> $10.00	Low
XXII 22nd Century Group	7/3/2023	Target Lowered by	Dawson James			$67.50 -> $15.00	Low
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
NRXP NRx Pharmaceuticals	3/17/2023	Reiterated by	Dawson James	Analyst J. Kolbert	Buy		Low
GOVX GeoVax Labs	3/3/2023	Initiated by	Dawson James		Buy	$4.00	Low
SMSI Smith Micro Software	2/28/2023	Target Lowered by	Dawson James			$8.30 -> $3.50	Low
SRNE Sorrento Therapeutics	2/13/2023	Downgraded by	Dawson James		Buy -> Neutral		N/A
GNPX Genprex	1/30/2023	Initiated by	Dawson James		Buy	$3.00	Low
ZOM Zomedica	1/6/2023	Initiated by	Dawson James	Analyst J. Kolbert	Buy	$6.00	N/A
CHEK Check-Cap	9/15/2022	Downgraded by	Dawson James	Analyst J. Kolbert	Buy -> Neutral		Low
BYRN Byrna Technologies	9/8/2022	Target Lowered by	Dawson James			$12.00 -> $9.50	Low
PRPH ProPhase Labs	7/21/2022	Downgraded by	Dawson James		Neutral -> Sell		Low
DYAI Dyadic International	7/18/2022	Downgraded by	Dawson James	Analyst J. Kolbert	Buy -> Neutral		Low
BYRN Byrna Technologies	4/26/2022	Initiated by	Dawson James		Buy	$12.00	High
LCTX Lineage Cell Therapeutics	3/11/2022	Reiterated by	Dawson James	Analyst Jason Kolbert	Buy	$6.00	N/A
SMSI Smith Micro Software	3/11/2022	Target Lowered by	Dawson James		Buy	$11.40 -> $8.30	High
PFIE Profire Energy	3/9/2022	Target Raised by	Dawson James			$1.65 -> $2.00	Low
KNWN Know Labs	2/8/2022	Initiated by	Dawson James		Buy	$7.00	High
CHEK Check-Cap	2/7/2022	Upgraded by	Dawson James		Neutral -> Buy		High
XXII 22nd Century Group	1/6/2022	Target Raised by	Dawson James	Analyst James McIlree	Buy -> Buy	$105.00 -> $127.50	N/A
VUZI Vuzix	12/21/2021	Initiated by	Dawson James		Buy	$15.00	Medium
PRPH ProPhase Labs	10/13/2021	Downgraded by	Dawson James	Analyst J. Kolbert	Buy -> Neutral		Medium
PFIE Profire Energy	8/5/2021	Initiated by	Dawson James	Analyst James McIlree	Buy	$1.65	High
SMSI Smith Micro Software	8/5/2021	Initiated by	Dawson James		Buy	$11.10	High
AVXL Anavex Life Sciences	6/21/2021	Target Raised by	Dawson James		Buy	$19.00 -> $35.00	Low
CHEK Check-Cap	3/17/2021	Reiterated by	Dawson James	Analyst J. Kolbert	Buy -> Neutral	$40.00	Low
CTXR Citius Pharmaceuticals	2/25/2021	Reiterated by	Dawson James	Analyst J. Kolbert	Buy	$6.00	Low
FBIO Fortress Biotech	2/17/2021	Target Raised by	Dawson James		Buy	$16.00 -> $21.00	Low
PRPH ProPhase Labs	1/20/2021	Initiated by	Dawson James		Buy	$25.00	High
LCTX Lineage Cell Therapeutics	10/12/2020	Reiterated by	Dawson James		Buy	$6.00	N/A
CTXR Citius Pharmaceuticals	9/17/2020	Reiterated by	Dawson James	Analyst J. Kolbert	Buy		Low
DARE Daré Bioscience	7/12/2020	Reiterated by	Dawson James		Buy	$3.00	High
AVXL Anavex Life Sciences	6/8/2020	Reiterated by	Dawson James		Buy	$16.00	Medium
SRNE Sorrento Therapeutics	5/26/2020	Initiated by	Dawson James		Buy -> Buy	$24.00	Low
CTSO Cytosorbents	3/9/2020	Reiterated by	Dawson James		Buy	$15.00 -> $17.00	High
DYAI Dyadic International	2/26/2020	Reiterated by	Dawson James	Analyst Jason Kolbert	Buy		High
IMAC IMAC	1/14/2020	Reiterated by	Dawson James	Analyst J. Kolbert	Buy -> Neutral		Low

MESO Mesoblast	12/19/2019	Initiated by	Dawson James	Analyst Jason Kolbert	Buy	$14.00	Low
CHEK Check-Cap	12/5/2019	Initiated by	Dawson James		Buy	$80.00	Low
DYAI Dyadic International	10/16/2019	Initiated by	Dawson James		Buy	$14.00	Low
CTXR Citius Pharmaceuticals	9/6/2019	Initiated by	Dawson James	Analyst Jason Kolbert	Buy	$7.00	N/A
FBIO Fortress Biotech	8/26/2019	Initiated by	Dawson James		Buy	$19.00	High
ADMA ADMA Biologics	8/12/2019	Downgraded by	Dawson James	Analyst J. Kolbert	Buy -> Neutral	$4.00	High
AVXL Anavex Life Sciences	7/24/2019	Initiated by	Dawson James	Analyst J. Kolbert	Buy	$16.00	Low
INTT inTEST	12/28/2018	Reiterated by	Dawson James	Analyst B. Sine	Buy		High
ORGS Orgenesis	12/20/2018	Reiterated by	Dawson James	Analyst C. Werther	Buy		High
SSNT SilverSun Technologies	12/19/2018	Reiterated by	Dawson James	Analyst B. Sine	Buy		High
ORGS Orgenesis	12/20/2018	Initiated by	Dawson James		Buy -> Buy		Medium
WYY WidePoint	12/3/2018	Reiterated by	Dawson James	Analyst B. Sine	Buy		High
WTT Wireless Telecom Group	12/3/2018	Reiterated by	Dawson James	Analyst B. Sine	Buy		Low
CNVS Cineverse	10/22/2018	Initiated by	Dawson James	Analyst B. Sine	Buy		Low
FRX Fennec Pharmaceuticals	10/10/2018	Reiterated by	Dawson James	Analyst C. Werther	Buy		N/A
FENC Fennec Pharmaceuticals	10/11/2018	Initiated by	Dawson James	Analyst C. Werther	Buy		High
LUNA Luna Innovations	10/2/2018	Initiated by	Dawson James	Analyst B. Sine	Buy		Low
SSKN STRATA Skin Sciences	9/4/2018	Initiated by	Dawson James	Analyst R. Wasserman	Buy		High
VERU Veru	6/25/2018	Reiterated by	Dawson James	Analyst R. Wasserman	Buy		Medium
IMV IMV	6/19/2018	Reiterated by	Dawson James	Analyst C. Werther	Buy		N/A
LVO LiveOne	6/4/2018	Reiterated by	Dawson James	Analyst B. Sine	Buy		Medium
ALT Altimmune	5/29/2018	Reiterated by	Dawson James	Analyst R. Wasserman	Buy		High
ACST Acasti Pharma	1/29/2018	Reiterated by	Dawson James	Analyst R. Wasserman	Buy		Low
CVM CEL-SCI	10/16/2017	Reiterated by	Dawson James	Analyst R. Wasserman	Neutral		N/A
PAVM PAVmed	9/5/2017	Reiterated by	Dawson James	Analyst R. Wasserman	Buy	$10.10	High
EPIX ESSA Pharma	8/3/2017	Reiterated by	Dawson James	Analyst R. Wasserman	Buy		High
ONTX Onconova Therapeutics	7/25/2017	Reiterated by	Dawson James	Analyst R. Wasserman	Buy		High
CVM CEL-SCI	3/11/2016	Reiterated by	Dawson James	Analyst R. Wasserman	Buy		N/A
ENZ Enzo Biochem	2/9/2016	Reiterated by	Dawson James	Analyst R. Wasserman	Buy		N/A
SLNO Soleno Therapeutics	5/6/2015	Initiated by	Dawson James		Buy	$952.50	N/A
CVM CEL-SCI	3/2/2015	Initiated by	Dawson James		Buy	$3.00	N/A
AXGN AxoGen	5/14/2014	Initiated by	Dawson James		Buy	$5.00	N/A
NEO NeoGenomics	5/14/2014	Initiated by	Dawson James		Buy	$6.00	N/A
ABIO ARCA biopharma	10/9/2013	Initiated by	Dawson James		Buy	$3.75	N/A
AGEN Agenus	3/12/2013	Reiterated by	Dawson James		Buy		N/A
MD Pediatrix Medical Group	3/12/2013	Downgraded by	Dawson James		Buy -> Neutral	$80.00	N/A
ARWR Arrowhead Pharmaceuticals	2/26/2013	Initiated by	Dawson James		Buy	$4.00	N/A
ATOS Atossa Therapeutics	12/20/2012	Initiated by	Dawson James		Outperform	$120.00	N/A
BMY Bristol-Myers Squibb	12/12/2012	Reiterated by	Dawson James		Market Outperform	$51.00	N/A
AMGN Amgen	12/7/2012	Initiated by	Dawson James		Outperform	$91.00	N/A
GEO The GEO Group	12/4/2012	Downgraded by	Dawson James		Market Perform		N/A
SRPT Sarepta Therapeutics	11/27/2012	Initiated by	Dawson James		Outperform		N/A
RMTI Rockwell Medical	11/27/2012	Initiated by	Dawson James		Outperform	$132.00	N/A
AGEN Agenus	11/27/2012	Initiated by	Dawson James		Outperform		N/A
SLS SELLAS Life Sciences Group	11/27/2012	Initiated by	Dawson James		Outperform	$150.00	N/A
CYTK Cytokinetics	11/27/2012	Downgraded by	Dawson James		Outperform		N/A
GALT Galectin Therapeutics	7/6/2012	Target Lowered by	Dawson James		Buy	$3.00	N/A
NFLX Netflix	10/28/2011	Target Lowered by	Dawson James		Sell	$16.50 -> $7.14	N/A

MarketBeat Community Rating for Dawson James

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		21,026 (Vote Outperform)
Underperform Votes:		17,693 (Vote Underperform)
Total Votes:		38,719

MarketBeat's community ratings are surveys of what our community members think about Dawson James and other research firms. Vote "Outperform" if you believe Dawson James's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Dawson James's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Dawson James Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Dawson James

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info